ArticleSurgical case reports2025
Hydronephrosis Caused by Polyglycolic Acid Spacer Placement Prior to Carbon Ion Radiotherapy for Local Recurrence of Rectal Cancer: Case Report.
Article in Surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCarbon-ion radiotherapy (CIRT) for pelvic recurrent rectal cancer has recently attracted attention due to its excellent therapeutic outcomes. A spacer is often inserted before CIRT to ensure a certain distance between the recurrent lesion and the adjacent intestine. We report a case of hydronephrosis due to ureteral stenosis after laparoscopic insertion of a polyglycolic acid (PGA) spacer. CASE PRESENTATION: A 58-year-old man underwent laparoscopic abdominoperineal resection and right lateral lymph node dissection after neoadjuvant chemoradiotherapy. He had been free of recurrence for 4 years. PET-CT 4.5 years after surgery revealed a 9-mm lymph node enlargement with an SUVmax = 2.88 in the left lateral region. Laparoscopic left lateral lymph node dissection was performed due to suspicion of recurrence, but removal was difficult due to severe fibrosis after previous radiation therapy. Definitive diagnosis of recurrence had not been made, so the patient was observed without treatment, but PET-CT 7 years after the initial surgery showed that the lymph node had enlarged to 25 mm with uptake of SUVmax = 8.06. Recurrence was strongly suspected, so we planned CIRT, and PGA spacer insertion was performed laparoscopically in advance. CT 3 days after insertion of the PGA spacer revealed hydronephrosis due to ureteral stenosis, which was thought to be caused by compression from the PGA spacer. Follow-up CT taken 7 days after surgery showed no improvement, so a ureteral stent was placed. Ureteral stenosis has persisted, so the ureteral stent has been replaced every 3 months. Regarding the recurrent lesions after CIRT, a tendency for them to shrink was observed on CT taken 1.5 years after the procedure.
conclusionsIn this case, a PGA spacer was inserted laparoscopically and hydronephrosis occurred early due to ureteral stenosis. Although the ureteral stenosis in the early postoperative period was thought to be caused by the PGA spacer, the persistence of ureteral stenosis was thought to be a late adverse event of CIRT. In cases where the ureter is exposed, such as after lateral lymph node dissection with neoadjuvant chemoradiotherapy, prophylactic ureteral stenting before inserting a PGA spacer may be considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.